Key result
Microalbuminuria acts as a specific marker to detect early arterial disease and renal damage in hypertensive patients, and its detection and treatment can significantly alter disease progression.
Microalbuminuria serves as a specific marker for early arterial disease and renal damage in hypertensive patients, and its detection and treatment can alter disease progression.
Answers are grounded in this paper and cite their sources.
Microalbuminuria screening should not yet alter hypertension care; leaves open need for prospective validation of progression impact.
Hypertension is one of the most common diseases of the modern world. In hypertensive patients, Microalbuminuria, defined as albumin excretion rate (AER) of 30-300 mg/day or 30 - 299 mg/gm of creatinine, acts as a specific marker to detect early arterial disease&renal damage. Detection of microalbuminuria in hypertensive patients and their treatment can significantly alter the disease progression.
No takes yet. Share an insight, caveat, or question.
Sabharwal et al. (2013) conducted a review in Hypertension. Microalbuminuria was evaluated. Microalbuminuria acts as a specific marker to detect early arterial disease and renal damage in hypertensive patients, and its detection and treatment can significantly alter disease progression.
Synapse has enriched 10 related papers. Consider them for comparative context: